Presented by
IVBM Event Coverage
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
Explore how the Veteran Affairs (VA) MS Centers of Excellence enhance veteran care through a hub-and-spoke model, telehealth, and groundbreaking research.
Improving Cancer Care Equity in Louisiana: Melanie Sheen, MD
Ochsner MD Anderson expands cancer care access in Louisiana through community partnerships, technology, and strong patient-physician relationships.
How Alzheimer Treatment Delivery Must Evolve: Darla Chapman, DNP
Nurse practitioners play an essential role in diagnosing, treating, and supporting individuals living with Alzheimer disease.
Improving Clinical Trial Diversity by Building Trust: Melanie Sheen, MD
Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and equitable patient engagement.
Innovative Oncology Care Strategies Addressing Social Determinants of Health: Lingling Du, MD
Oncology care advances target social determinants of health through AI, patient education, and community engagement.
How MS Treatment Strategies Are Evolving: Rebecca Spain, MD
Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.
Early Alzheimer Diagnosis Key to Better Outcomes: Darla Chapman, DNP
Darla Chapman, DNP, ARNP, University of Washington, speaks on the evolution of Alzheimer diagnosis, emphasizing early detection and innovative biomarkers.
Using AI to Individualize Clinical Pathways Is the Future of Precision Oncology: Joshua K. Sabari, MD
Using artificial intelligence (AI) to specialize treatment for patients with different kinds of cancer can be a boon to clinicians looking to personalize their care.
Remote Monitoring May Improve Heart Failure Outcomes: Anitha Vijayan, MD
Guideline-directed medical therapy used with remote monitoring can potentially reduce hospitalization in patients with heart failure with ejection fraction.
Clinicians Should Look Beyond NGS When Delivering Precision Oncology: Joshua K. Sabari, MD
New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best therapeutic options for patients with cancer.
Defining the Comprehensive Role of the Oncology Pharmacist in Multiple Myeloma: Marcus Flores, PharmD, BCPS, BCOP
Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring collaboration, patient-centered strategies, and AI.
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
Ken Cohen, MD, FACP, discusses how new cognitive assessment tools are improving Alzheimer disease diagnosis.
Cancer Care Strategies Addressing Social Determinants of Health: Susan Escudier, MD
Susan Escudier, MD, FACP, of Texas Oncology, suggests actionable insights to improve equitable access to patient cancer care
Overcoming SDOH Barriers in Cancer Care: Susan Escudier, MD
Incorporating tools that gauge social determinants of health can improve patient access to cancer care, explained Susan Escudier, MD.
Identifying Treatment, Support Pathways After Cognitive Screening: Ken Cohen, MD, FACP
Ken Cohen, MD, FACP, discusses how clinicians can support patients after a cognitive screening to identify meaningful next steps.
Financial Barriers to Accessing Oncology Care With Susan Escudier, MD
Susan Escudier, MD, discusses the practical implications of financial barriers for patients with cancer accessing oncology care.
Neurodegenerative Diseases Are a Rising Health Care Priority: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, discusses the rising global burden of neurodegenerative diseases.
Overcoming Access, Cost Barriers in MS: Andrew Wolf, MD
Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care.
Addressing Complexities of Alzheimer Disease Care Coordination: Tara Carlisle, MD, PhD
Tara Carlisle, MD, PhD, University of Colorado, discusses how coordinated care efforts and frequent safety monitoring are transforming early Alzheimer disease management.
Innovations and Challenges in Screening for Alzheimer Disease: Ken Cohen, MD, FACP
Ken Cohen, MD, FACP, discusses the importance of expanding cognitive screening for seniors.
Why Education and Collaboration Are Key to Bispecific Therapy Administration: Amir Fathi, MD
Experts discuss the importance of initiating blinatumomab treatment for acute lymphoid leukemia in academic centers for optimal patient care.
Behind the Scenes of Multiple Myeloma Care: A Pharmacist’s View With Kelley L. Julian, PharmD, BCOP
Kelley L. Julian, PharmD, BCOP, discusses optimizing myeloma care, addressing barriers in access to intravenous immunoglobulin and innovative therapies at Huntsman Cancer Institute.
Maintaining Incremental Weight Loss and Diets: David Rometo, MD
David Rometo, MD, reflects on the sustainability of incremental weight loss programs and aggressive diets.
Weight Loss Treatment Variability and Cost-Effectiveness: David Rometo, MD
David Rometo, MD, weighs various weight loss treatments, their success, and sustainability.
Addressing Common Stigmas in Weight Loss: David Rometo, MD
David Rometo, MD, of UPMC, addresses stigma surrounding obesity and group setting weight loss intervention therapies and how consults benefit patients.
Clinician's Role in Breast Cancer Care, Access: Lakshminarayanan Nandagopal, MD
Clinician's role in breast cancer care and access with reproductive and urinary oncologist Lakshminarayanan Nandagopal, MD
Building Sustainable Navigation, SDOH Support in Cancer Care: Hope Krebill, MSW, BSN, RN
Hope Krebill of the Masonic Cancer Alliance at the University of Kansas Medical Center outlines patient navigation models that improve outcomes and reduce missed appointments.
Evaluating Current Breast Cancer Care, Treatments: Lakshminarayanan Nandagopal, MD
Advancements in breast cancer care and treatments with reproductive and urinary oncologist Lakshminarayanan Nandagopal, MD.
Bringing Advanced Cancer Therapies to Rural Communities: Hope Krebill, MSW, BSN, RN
Hope Krebill, MSW, BSN, RN, discusses the challenges rural hospitals face in delivering therapies like CAR T and bispecifics.
Expanding Clinical Trial Access for Underserved Patients: Hope Krebill, MSW, BSN, RN
From proactive recruitment to academic-community partnerships, Hope Krebill highlights ways to improve clinical trial participation.
